Maturity-onset diabetes of the young type 3 (HNF1A-MODY) research hub

Effects of empagliflozin on plasma glucose in patients with HNF1A-MODY: a randomized, double-blind, crossover trial

This study looks at how a drug called empagliflozin (Jardiance) affects blood sugar in people with a specific type of diabetes called HNF1A-MODY. It compares this drug to a dummy pill (placebo) to see if it helps manage blood sugar levels.